UK's Alliance Pharma soars after agreeing to DBAY takeover
10/01/2025 08:45
** Shares of Alliance Pharma Plc ALAPH.L surge as much as
39% to 61.5p, stock top pct gainer across London
** Stock set to post best day ever, if trend holds
** UK healthcare group agrees to be acquired by asset
management firm DBAY Advisors in an all-cash deal valuing it at
349.7 mln pounds ($429.6 mln)
** The 62.5p-per-share offer represents a premium of about
41% to stock's Thursday close
** Acquisition is expected to be completed in H1 of 2025;
Alliance board says it intends to unanimously recommend that
shareholders vote in favour of the deal
** ALAPH gained 13% in 2024
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))